Illinois General Assembly

Previous General Assemblies

Full Text of SB3697  97th General Assembly

SB3697eng 97TH GENERAL ASSEMBLY

  
  
  

 


 
SB3697 EngrossedLRB097 18495 RLC 63726 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 102 as follows:
 
6    (720 ILCS 570/102)  (from Ch. 56 1/2, par. 1102)
7    Sec. 102. Definitions. As used in this Act, unless the
8context otherwise requires:
9    (a) "Addict" means any person who habitually uses any drug,
10chemical, substance or dangerous drug other than alcohol so as
11to endanger the public morals, health, safety or welfare or who
12is so far addicted to the use of a dangerous drug or controlled
13substance other than alcohol as to have lost the power of self
14control with reference to his or her addiction.
15    (b) "Administer" means the direct application of a
16controlled substance, whether by injection, inhalation,
17ingestion, or any other means, to the body of a patient,
18research subject, or animal (as defined by the Humane
19Euthanasia in Animal Shelters Act) by:
20        (1) a practitioner (or, in his or her presence, by his
21    or her authorized agent),
22        (2) the patient or research subject pursuant to an
23    order, or

 

 

SB3697 Engrossed- 2 -LRB097 18495 RLC 63726 b

1        (3) a euthanasia technician as defined by the Humane
2    Euthanasia in Animal Shelters Act.
3    (c) "Agent" means an authorized person who acts on behalf
4of or at the direction of a manufacturer, distributor,
5dispenser, prescriber, or practitioner. It does not include a
6common or contract carrier, public warehouseman or employee of
7the carrier or warehouseman.
8    (c-1) "Anabolic Steroids" means any drug or hormonal
9substance, chemically and pharmacologically related to
10testosterone (other than estrogens, progestins,
11corticosteroids, and dehydroepiandrosterone), and includes:
12    (i) 3[beta],17-dihydroxy-5a-androstane, 
13    (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane, 
14    (iii) 5[alpha]-androstan-3,17-dione, 
15    (iv) 1-androstenediol (3[beta], 
16        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
17    (v) 1-androstenediol (3[alpha], 
18        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
19    (vi) 4-androstenediol  
20        (3[beta],17[beta]-dihydroxy-androst-4-ene), 
21    (vii) 5-androstenediol  
22        (3[beta],17[beta]-dihydroxy-androst-5-ene), 
23    (viii) 1-androstenedione  
24        ([5alpha]-androst-1-en-3,17-dione), 
25    (ix) 4-androstenedione  
26        (androst-4-en-3,17-dione), 

 

 

SB3697 Engrossed- 3 -LRB097 18495 RLC 63726 b

1    (x) 5-androstenedione  
2        (androst-5-en-3,17-dione), 
3    (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]- 
4        hydroxyandrost-4-en-3-one), 
5    (xii) boldenone (17[beta]-hydroxyandrost- 
6        1,4,-diene-3-one), 
7    (xiii) boldione (androsta-1,4- 
8        diene-3,17-dione), 
9    (xiv) calusterone (7[beta],17[alpha]-dimethyl-17 
10        [beta]-hydroxyandrost-4-en-3-one), 
11    (xv) clostebol (4-chloro-17[beta]- 
12        hydroxyandrost-4-en-3-one), 
13    (xvi) dehydrochloromethyltestosterone (4-chloro- 
14        17[beta]-hydroxy-17[alpha]-methyl- 
15        androst-1,4-dien-3-one), 
16    (xvii) desoxymethyltestosterone 
17    (17[alpha]-methyl-5[alpha] 
18        -androst-2-en-17[beta]-ol)(a.k.a., madol), 
19    (xviii) [delta]1-dihydrotestosterone (a.k.a.  
20        '1-testosterone') (17[beta]-hydroxy- 
21        5[alpha]-androst-1-en-3-one), 
22    (xix) 4-dihydrotestosterone (17[beta]-hydroxy- 
23        androstan-3-one), 
24    (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl- 
25        5[alpha]-androstan-3-one), 
26    (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]- 

 

 

SB3697 Engrossed- 4 -LRB097 18495 RLC 63726 b

1        hydroxyestr-4-ene), 
2    (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl- 
3        1[beta],17[beta]-dihydroxyandrost-4-en-3-one), 
4    (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha], 
5        17[beta]-dihydroxyandrost-1,4-dien-3-one), 
6    (xxiv) furazabol (17[alpha]-methyl-17[beta]- 
7        hydroxyandrostano[2,3-c]-furazan), 
8    (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one) 
9    (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy- 
10        androst-4-en-3-one), 
11    (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]- 
12        dihydroxy-estr-4-en-3-one), 
13    (xxviii) mestanolone (17[alpha]-methyl-17[beta]- 
14        hydroxy-5-androstan-3-one), 
15    (xxix) mesterolone (1amethyl-17[beta]-hydroxy- 
16        [5a]-androstan-3-one), 
17    (xxx) methandienone (17[alpha]-methyl-17[beta]- 
18        hydroxyandrost-1,4-dien-3-one), 
19    (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]- 
20        dihydroxyandrost-5-ene), 
21    (xxxii) methenolone (1-methyl-17[beta]-hydroxy- 
22        5[alpha]-androst-1-en-3-one), 
23    (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]- 
24        dihydroxy-5a-androstane), 
25    (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy 
26        -5a-androstane), 

 

 

SB3697 Engrossed- 5 -LRB097 18495 RLC 63726 b

1    (xxxv) 17[alpha]-methyl-3[beta],17[beta]- 
2        dihydroxyandrost-4-ene), 
3    (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]- 
4        methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one), 
5    (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]- 
6        hydroxyestra-4,9(10)-dien-3-one), 
7    (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]- 
8        hydroxyestra-4,9-11-trien-3-one), 
9    (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]- 
10        hydroxyandrost-4-en-3-one), 
11    (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]- 
12        hydroxyestr-4-en-3-one), 
13    (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone  
14        (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]- 
15        androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl- 
16        1-testosterone'), 
17    (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one), 
18    (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]- 
19        dihydroxyestr-4-ene), 
20    (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]- 
21        dihydroxyestr-4-ene), 
22    (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]- 
23        dihydroxyestr-5-ene), 
24    (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]- 
25        dihydroxyestr-5-ene), 
26    (xlvii) 19-nor-4,9(10)-androstadienedione  

 

 

SB3697 Engrossed- 6 -LRB097 18495 RLC 63726 b

1        (estra-4,9(10)-diene-3,17-dione), 
2    (xlviii) 19-nor-4-androstenedione (estr-4- 
3        en-3,17-dione), 
4    (xlix) 19-nor-5-androstenedione (estr-5- 
5        en-3,17-dione), 
6    (l) norbolethone (13[beta], 17a-diethyl-17[beta]- 
7        hydroxygon-4-en-3-one), 
8    (li) norclostebol (4-chloro-17[beta]- 
9        hydroxyestr-4-en-3-one), 
10    (lii) norethandrolone (17[alpha]-ethyl-17[beta]- 
11        hydroxyestr-4-en-3-one), 
12    (liii) normethandrolone (17[alpha]-methyl-17[beta]- 
13        hydroxyestr-4-en-3-one), 
14    (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy- 
15        2-oxa-5[alpha]-androstan-3-one), 
16    (lv) oxymesterone (17[alpha]-methyl-4,17[beta]- 
17        dihydroxyandrost-4-en-3-one), 
18    (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene- 
19        17[beta]-hydroxy-(5[alpha]-androstan-3-one), 
20    (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy- 
21        (5[alpha]-androst-2-eno[3,2-c]-pyrazole), 
22    (lviii) stenbolone (17[beta]-hydroxy-2-methyl- 
23        (5[alpha]-androst-1-en-3-one), 
24    (lix) testolactone (13-hydroxy-3-oxo-13,17- 
25        secoandrosta-1,4-dien-17- 
26        oic acid lactone), 

 

 

SB3697 Engrossed- 7 -LRB097 18495 RLC 63726 b

1    (lx) testosterone (17[beta]-hydroxyandrost- 
2        4-en-3-one), 
3    (lxi) tetrahydrogestrinone (13[beta], 17[alpha]- 
4        diethyl-17[beta]-hydroxygon- 
5        4,9,11-trien-3-one), 
6    (lxii) trenbolone (17[beta]-hydroxyestr-4,9, 
7        11-trien-3-one). 
8    Any person who is otherwise lawfully in possession of an
9anabolic steroid, or who otherwise lawfully manufactures,
10distributes, dispenses, delivers, or possesses with intent to
11deliver an anabolic steroid, which anabolic steroid is
12expressly intended for and lawfully allowed to be administered
13through implants to livestock or other nonhuman species, and
14which is approved by the Secretary of Health and Human Services
15for such administration, and which the person intends to
16administer or have administered through such implants, shall
17not be considered to be in unauthorized possession or to
18unlawfully manufacture, distribute, dispense, deliver, or
19possess with intent to deliver such anabolic steroid for
20purposes of this Act.
21    (d) "Administration" means the Drug Enforcement
22Administration, United States Department of Justice, or its
23successor agency.
24    (d-5) "Clinical Director, Prescription Monitoring Program"
25means a Department of Human Services administrative employee
26licensed to either prescribe or dispense controlled substances

 

 

SB3697 Engrossed- 8 -LRB097 18495 RLC 63726 b

1who shall run the clinical aspects of the Department of Human
2Services Prescription Monitoring Program and its Prescription
3Information Library.
4    (d-10) "Compounding" means the preparation and mixing of
5components, excluding flavorings, (1) as the result of a
6prescriber's prescription drug order or initiative based on the
7prescriber-patient-pharmacist relationship in the course of
8professional practice or (2) for the purpose of, or incident
9to, research, teaching, or chemical analysis and not for sale
10or dispensing. "Compounding" includes the preparation of drugs
11or devices in anticipation of receiving prescription drug
12orders based on routine, regularly observed dispensing
13patterns. Commercially available products may be compounded
14for dispensing to individual patients only if both of the
15following conditions are met: (i) the commercial product is not
16reasonably available from normal distribution channels in a
17timely manner to meet the patient's needs and (ii) the
18prescribing practitioner has requested that the drug be
19compounded.
20    (e) "Control" means to add a drug or other substance, or
21immediate precursor, to a Schedule whether by transfer from
22another Schedule or otherwise.
23    (f) "Controlled Substance" means (i) a drug, substance, or
24immediate precursor in the Schedules of Article II of this Act
25or (ii) a drug or other substance, or immediate precursor,
26designated as a controlled substance by the Department through

 

 

SB3697 Engrossed- 9 -LRB097 18495 RLC 63726 b

1administrative rule. The term does not include distilled
2spirits, wine, malt beverages, or tobacco, as those terms are
3defined or used in the Liquor Control Act and the Tobacco
4Products Tax Act.
5    (f-5) "Controlled substance analog" means a substance:
6        (1) the chemical structure of which is substantially
7    similar to the chemical structure of a controlled substance
8    in Schedule I or II;
9        (2) which has a stimulant, depressant, or
10    hallucinogenic effect on the central nervous system that is
11    substantially similar to or greater than the stimulant,
12    depressant, or hallucinogenic effect on the central
13    nervous system of a controlled substance in Schedule I or
14    II; or
15        (3) with respect to a particular person, which such
16    person represents or intends to have a stimulant,
17    depressant, or hallucinogenic effect on the central
18    nervous system that is substantially similar to or greater
19    than the stimulant, depressant, or hallucinogenic effect
20    on the central nervous system of a controlled substance in
21    Schedule I or II.
22    (g) "Counterfeit substance" means a controlled substance,
23which, or the container or labeling of which, without
24authorization bears the trademark, trade name, or other
25identifying mark, imprint, number or device, or any likeness
26thereof, of a manufacturer, distributor, or dispenser other

 

 

SB3697 Engrossed- 10 -LRB097 18495 RLC 63726 b

1than the person who in fact manufactured, distributed, or
2dispensed the substance.
3    (h) "Deliver" or "delivery" means the actual, constructive
4or attempted transfer of possession of a controlled substance,
5with or without consideration, whether or not there is an
6agency relationship.
7    (i) "Department" means the Illinois Department of Human
8Services (as successor to the Department of Alcoholism and
9Substance Abuse) or its successor agency.
10    (j) (Blank).
11    (k) "Department of Corrections" means the Department of
12Corrections of the State of Illinois or its successor agency.
13    (l) "Department of Financial and Professional Regulation"
14means the Department of Financial and Professional Regulation
15of the State of Illinois or its successor agency.
16    (m) "Depressant" means any drug that (i) causes an overall
17depression of central nervous system functions, (ii) causes
18impaired consciousness and awareness, and (iii) can be
19habit-forming or lead to a substance abuse problem, including
20but not limited to alcohol, cannabis and its active principles
21and their analogs, benzodiazepines and their analogs,
22barbiturates and their analogs, opioids (natural and
23synthetic) and their analogs, and chloral hydrate and similar
24sedative hypnotics.
25    (n) (Blank).
26    (o) "Director" means the Director of the Illinois State

 

 

SB3697 Engrossed- 11 -LRB097 18495 RLC 63726 b

1Police or his or her designated agents.
2    (p) "Dispense" means to deliver a controlled substance to
3an ultimate user or research subject by or pursuant to the
4lawful order of a prescriber, including the prescribing,
5administering, packaging, labeling, or compounding necessary
6to prepare the substance for that delivery.
7    (q) "Dispenser" means a practitioner who dispenses.
8    (r) "Distribute" means to deliver, other than by
9administering or dispensing, a controlled substance.
10    (s) "Distributor" means a person who distributes.
11    (t) "Drug" means (1) substances recognized as drugs in the
12official United States Pharmacopoeia, Official Homeopathic
13Pharmacopoeia of the United States, or official National
14Formulary, or any supplement to any of them; (2) substances
15intended for use in diagnosis, cure, mitigation, treatment, or
16prevention of disease in man or animals; (3) substances (other
17than food) intended to affect the structure of any function of
18the body of man or animals and (4) substances intended for use
19as a component of any article specified in clause (1), (2), or
20(3) of this subsection. It does not include devices or their
21components, parts, or accessories.
22    (t-5) "Euthanasia agency" means an entity certified by the
23Department of Financial and Professional Regulation for the
24purpose of animal euthanasia that holds an animal control
25facility license or animal shelter license under the Animal
26Welfare Act. A euthanasia agency is authorized to purchase,

 

 

SB3697 Engrossed- 12 -LRB097 18495 RLC 63726 b

1store, possess, and utilize Schedule II nonnarcotic and
2Schedule III nonnarcotic drugs for the sole purpose of animal
3euthanasia.
4    (t-10) "Euthanasia drugs" means Schedule II or Schedule III
5substances (nonnarcotic controlled substances) that are used
6by a euthanasia agency for the purpose of animal euthanasia.
7    (u) "Good faith" means the prescribing or dispensing of a
8controlled substance by a practitioner in the regular course of
9professional treatment to or for any person who is under his or
10her treatment for a pathology or condition other than that
11individual's physical or psychological dependence upon or
12addiction to a controlled substance, except as provided herein:
13and application of the term to a pharmacist shall mean the
14dispensing of a controlled substance pursuant to the
15prescriber's order which in the professional judgment of the
16pharmacist is lawful. The pharmacist shall be guided by
17accepted professional standards including, but not limited to
18the following, in making the judgment:
19        (1) lack of consistency of prescriber-patient
20    relationship,
21        (2) frequency of prescriptions for same drug by one
22    prescriber for large numbers of patients,
23        (3) quantities beyond those normally prescribed,
24        (4) unusual dosages (recognizing that there may be
25    clinical circumstances where more or less than the usual
26    dose may be used legitimately),

 

 

SB3697 Engrossed- 13 -LRB097 18495 RLC 63726 b

1        (5) unusual geographic distances between patient,
2    pharmacist and prescriber,
3        (6) consistent prescribing of habit-forming drugs.
4    (u-0.5) "Hallucinogen" means a drug that causes markedly
5altered sensory perception leading to hallucinations of any
6type.
7    (u-1) "Home infusion services" means services provided by a
8pharmacy in compounding solutions for direct administration to
9a patient in a private residence, long-term care facility, or
10hospice setting by means of parenteral, intravenous,
11intramuscular, subcutaneous, or intraspinal infusion.
12    (u-5) "Illinois State Police" means the State Police of the
13State of Illinois, or its successor agency.
14    (v) "Immediate precursor" means a substance:
15        (1) which the Department has found to be and by rule
16    designated as being a principal compound used, or produced
17    primarily for use, in the manufacture of a controlled
18    substance;
19        (2) which is an immediate chemical intermediary used or
20    likely to be used in the manufacture of such controlled
21    substance; and
22        (3) the control of which is necessary to prevent,
23    curtail or limit the manufacture of such controlled
24    substance.
25    (w) "Instructional activities" means the acts of teaching,
26educating or instructing by practitioners using controlled

 

 

SB3697 Engrossed- 14 -LRB097 18495 RLC 63726 b

1substances within educational facilities approved by the State
2Board of Education or its successor agency.
3    (x) "Local authorities" means a duly organized State,
4County or Municipal peace unit or police force.
5    (y) "Look-alike substance" means a substance, other than a
6controlled substance which (1) by overall dosage unit
7appearance, including shape, color, size, markings or lack
8thereof, taste, consistency, or any other identifying physical
9characteristic of the substance, would lead a reasonable person
10to believe that the substance is a controlled substance, or (2)
11is expressly or impliedly represented to be a controlled
12substance or is distributed under circumstances which would
13lead a reasonable person to believe that the substance is a
14controlled substance. For the purpose of determining whether
15the representations made or the circumstances of the
16distribution would lead a reasonable person to believe the
17substance to be a controlled substance under this clause (2) of
18subsection (y), the court or other authority may consider the
19following factors in addition to any other factor that may be
20relevant:
21        (a) statements made by the owner or person in control
22    of the substance concerning its nature, use or effect;
23        (b) statements made to the buyer or recipient that the
24    substance may be resold for profit;
25        (c) whether the substance is packaged in a manner
26    normally used for the illegal distribution of controlled

 

 

SB3697 Engrossed- 15 -LRB097 18495 RLC 63726 b

1    substances;
2        (d) whether the distribution or attempted distribution
3    included an exchange of or demand for money or other
4    property as consideration, and whether the amount of the
5    consideration was substantially greater than the
6    reasonable retail market value of the substance.
7    Clause (1) of this subsection (y) shall not apply to a
8noncontrolled substance in its finished dosage form that was
9initially introduced into commerce prior to the initial
10introduction into commerce of a controlled substance in its
11finished dosage form which it may substantially resemble.
12    Nothing in this subsection (y) prohibits the dispensing or
13distributing of noncontrolled substances by persons authorized
14to dispense and distribute controlled substances under this
15Act, provided that such action would be deemed to be carried
16out in good faith under subsection (u) if the substances
17involved were controlled substances.
18    Nothing in this subsection (y) or in this Act prohibits the
19manufacture, preparation, propagation, compounding,
20processing, packaging, advertising or distribution of a drug or
21drugs by any person registered pursuant to Section 510 of the
22Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
23    (y-1) "Mail-order pharmacy" means a pharmacy that is
24located in a state of the United States that delivers,
25dispenses or distributes, through the United States Postal
26Service or other common carrier, to Illinois residents, any

 

 

SB3697 Engrossed- 16 -LRB097 18495 RLC 63726 b

1substance which requires a prescription.
2    (z) "Manufacture" means the production, preparation,
3propagation, compounding, conversion or processing of a
4controlled substance other than methamphetamine, either
5directly or indirectly, by extraction from substances of
6natural origin, or independently by means of chemical
7synthesis, or by a combination of extraction and chemical
8synthesis, and includes any packaging or repackaging of the
9substance or labeling of its container, except that this term
10does not include:
11        (1) by an ultimate user, the preparation or compounding
12    of a controlled substance for his or her own use; or
13        (2) by a practitioner, or his or her authorized agent
14    under his or her supervision, the preparation,
15    compounding, packaging, or labeling of a controlled
16    substance:
17            (a) as an incident to his or her administering or
18        dispensing of a controlled substance in the course of
19        his or her professional practice; or
20            (b) as an incident to lawful research, teaching or
21        chemical analysis and not for sale.
22    (z-1) (Blank).
23    (z-5) "Medication shopping" means the conduct prohibited
24under subsection (a) of Section 314.5 of this Act.
25    (z-10) "Mid-level practitioner" means (i) a physician
26assistant who has been delegated authority to prescribe through

 

 

SB3697 Engrossed- 17 -LRB097 18495 RLC 63726 b

1a written delegation of authority by a physician licensed to
2practice medicine in all of its branches, in accordance with
3Section 7.5 of the Physician Assistant Practice Act of 1987,
4(ii) an advanced practice nurse who has been delegated
5authority to prescribe through a written delegation of
6authority by a physician licensed to practice medicine in all
7of its branches or by a podiatrist, in accordance with Section
865-40 of the Nurse Practice Act, or (iii) an animal euthanasia
9agency.
10    (aa) "Narcotic drug" means any of the following, whether
11produced directly or indirectly by extraction from substances
12of vegetable origin, or independently by means of chemical
13synthesis, or by a combination of extraction and chemical
14synthesis:
15        (1) opium, opiates, derivatives of opium and opiates,
16    including their isomers, esters, ethers, salts, and salts
17    of isomers, esters, and ethers, whenever the existence of
18    such isomers, esters, ethers, and salts is possible within
19    the specific chemical designation; however the term
20    "narcotic drug" does not include the isoquinoline
21    alkaloids of opium;
22        (2) (blank);
23        (3) opium poppy and poppy straw;
24        (4) coca leaves, except coca leaves and extracts of
25    coca leaves from which substantially all of the cocaine and
26    ecgonine, and their isomers, derivatives and salts, have

 

 

SB3697 Engrossed- 18 -LRB097 18495 RLC 63726 b

1    been removed;
2        (5) cocaine, its salts, optical and geometric isomers,
3    and salts of isomers;
4        (6) ecgonine, its derivatives, their salts, isomers,
5    and salts of isomers;
6        (7) any compound, mixture, or preparation which
7    contains any quantity of any of the substances referred to
8    in subparagraphs (1) through (6).
9    (bb) "Nurse" means a registered nurse licensed under the
10Nurse Practice Act.
11    (cc) (Blank).
12    (dd) "Opiate" means any substance having an addiction
13forming or addiction sustaining liability similar to morphine
14or being capable of conversion into a drug having addiction
15forming or addiction sustaining liability.
16    (ee) "Opium poppy" means the plant of the species Papaver
17somniferum L., except its seeds.
18    (ee-5) "Oral dosage" means a tablet, capsule, elixir, or
19solution or other liquid form of medication intended for
20administration by mouth, but the term does not include a form
21of medication intended for buccal, sublingual, or transmucosal
22administration.
23    (ff) "Parole and Pardon Board" means the Parole and Pardon
24Board of the State of Illinois or its successor agency.
25    (gg) "Person" means any individual, corporation,
26mail-order pharmacy, government or governmental subdivision or

 

 

SB3697 Engrossed- 19 -LRB097 18495 RLC 63726 b

1agency, business trust, estate, trust, partnership or
2association, or any other entity.
3    (hh) "Pharmacist" means any person who holds a license or
4certificate of registration as a registered pharmacist, a local
5registered pharmacist or a registered assistant pharmacist
6under the Pharmacy Practice Act.
7    (ii) "Pharmacy" means any store, ship or other place in
8which pharmacy is authorized to be practiced under the Pharmacy
9Practice Act.
10    (ii-5) "Pharmacy shopping" means the conduct prohibited
11under subsection (b) of Section 314.5 of this Act.
12    (ii-10) "Physician" (except when the context otherwise
13requires) means a person licensed to practice medicine in all
14of its branches.
15    (jj) "Poppy straw" means all parts, except the seeds, of
16the opium poppy, after mowing.
17    (kk) "Practitioner" means a physician licensed to practice
18medicine in all its branches, dentist, optometrist,
19podiatrist, veterinarian, scientific investigator, pharmacist,
20physician assistant, advanced practice nurse, licensed
21practical nurse, registered nurse, hospital, laboratory, or
22pharmacy, or other person licensed, registered, or otherwise
23lawfully permitted by the United States or this State to
24distribute, dispense, conduct research with respect to,
25administer or use in teaching or chemical analysis, a
26controlled substance in the course of professional practice or

 

 

SB3697 Engrossed- 20 -LRB097 18495 RLC 63726 b

1research.
2    (ll) "Pre-printed prescription" means a written
3prescription upon which the designated drug has been indicated
4prior to the time of issuance; the term does not mean a written
5prescription that is individually generated by machine or
6computer in the prescriber's office.
7    (mm) "Prescriber" means a physician licensed to practice
8medicine in all its branches, dentist, optometrist, podiatrist
9or veterinarian who issues a prescription, a physician
10assistant who issues a prescription for a controlled substance
11in accordance with Section 303.05, a written delegation, and a
12written supervision agreement required under Section 7.5 of the
13Physician Assistant Practice Act of 1987, or an advanced
14practice nurse with prescriptive authority delegated under
15Section 65-40 of the Nurse Practice Act and in accordance with
16Section 303.05, a written delegation, and a written
17collaborative agreement under Section 65-35 of the Nurse
18Practice Act.
19    (nn) "Prescription" means a written, facsimile, or oral
20order, or an electronic order that complies with applicable
21federal requirements, of a physician licensed to practice
22medicine in all its branches, dentist, podiatrist or
23veterinarian for any controlled substance, of an optometrist
24for a Schedule III, IV, or V controlled substance in accordance
25with Section 15.1 of the Illinois Optometric Practice Act of
261987, of a physician assistant for a controlled substance in

 

 

SB3697 Engrossed- 21 -LRB097 18495 RLC 63726 b

1accordance with Section 303.05, a written delegation, and a
2written supervision agreement required under Section 7.5 of the
3Physician Assistant Practice Act of 1987, or of an advanced
4practice nurse with prescriptive authority delegated under
5Section 65-40 of the Nurse Practice Act who issues a
6prescription for a controlled substance in accordance with
7Section 303.05, a written delegation, and a written
8collaborative agreement under Section 65-35 of the Nurse
9Practice Act when required by law.
10    (nn-5) "Prescription Information Library" (PIL) means an
11electronic library that contains reported controlled substance
12data.
13    (nn-10) "Prescription Monitoring Program" (PMP) means the
14entity that collects, tracks, and stores reported data on
15controlled substances and select drugs pursuant to Section 316.
16    (oo) "Production" or "produce" means manufacture,
17planting, cultivating, growing, or harvesting of a controlled
18substance other than methamphetamine.
19    (pp) "Registrant" means every person who is required to
20register under Section 302 of this Act.
21    (qq) "Registry number" means the number assigned to each
22person authorized to handle controlled substances under the
23laws of the United States and of this State.
24    (qq-1) "School" means a preschool, kindergarten, nursery,
25elementary or secondary educational institution, vocational
26school, special educational facility, or any other elementary

 

 

SB3697 Engrossed- 22 -LRB097 18495 RLC 63726 b

1or secondary educational agency.
2    (qq-5) "Secretary" means, as the context requires, either
3the Secretary of the Department or the Secretary of the
4Department of Financial and Professional Regulation, and the
5Secretary's designated agents.
6    (rr) "State" includes the State of Illinois and any state,
7district, commonwealth, territory, insular possession thereof,
8and any area subject to the legal authority of the United
9States of America.
10    (rr-5) "Stimulant" means any drug that (i) causes an
11overall excitation of central nervous system functions, (ii)
12causes impaired consciousness and awareness, and (iii) can be
13habit-forming or lead to a substance abuse problem, including
14but not limited to amphetamines and their analogs,
15methylphenidate and its analogs, cocaine, and phencyclidine
16and its analogs.
17    (ss) "Ultimate user" means a person who lawfully possesses
18a controlled substance for his or her own use or for the use of
19a member of his or her household or for administering to an
20animal owned by him or her or by a member of his or her
21household.
22(Source: P.A. 96-189, eff. 8-10-09; 96-268, eff. 8-11-09;
2397-334, eff. 1-1-12.)